Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

Alopecia areata patients may have higher cardiovascular risk factors, so screening for metabolic syndrome components is suggested.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

VIP reduces hair pigmentation by decreasing melanin production.

People with severe hair loss have lower zinc levels in their blood.

Ritlecitinib is safe and may effectively treat alopecia areata.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

CLEC4D gene variants may increase the risk of alopecia areata in Jordanians.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

The Tru9I variant in the VDR gene may influence alopecia areata risk and vitamin D levels.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Hair follicle stem cells are promising for blood vessel formation and tissue repair.

Improving CRISPR/Cas systems can make gene editing more efficient and precise.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Targeting mitophagy may help treat alopecia areata by reducing inflammasome activation.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

A woman's complete hair loss condition improved after recovering from COVID-19.

Lack of vitamin D might cause hair loss due to autoimmune problems, and fixing vitamin D levels could help treat it.

Periplaneta americana extract helps hair regrowth by reducing inflammation and improving skin bacteria balance.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Tofacitinib helped regrow hair in a woman with alopecia areata.